Abstract

Hereditary hemorrhagic telangiectasia (HHT) is characterized by mucocutaneous telangiectases and visceral vascular malformations. Individuals suffering from HHT have a significantly increased risk of bacterial infections, but the mechanisms involved in this are not clear. White blood cell subpopulations were estimated with flow cytometry in 79 patients with HHT and 45 healthy individuals, and association with clinicopathological status was assessed. A prominent decrease in absolute numbers of T cells in HHT was revealed (0.7 (0.5–1.1) vs. 1.3 (0.8–1.6), 106/mL, p < 0.05), and in multivariate regression analysis, hemoglobin level was associated with lymphopenia (OR = 0.625, 95% CI: 0.417–0.937, p < 0.05). Although no changes in absolute numbers of neutrophils and monocytes were observed, we revealed a significant impairment of neutrophil antibacterial functions in HHT (n = 9), compared to healthy individuals (n = 7), in vitro. The release of neutrophil extracellular traps (NETs) against Pseudomonas aeruginosa MOI10 was significantly suppressed in HHT (mean area per cell, mm2: 76 (70–92) vs. 121 (97–128), p < 0.05), due to impaired filamentous actin organization (% of positive cells: 69 (59–77) vs. 92 (88–94), p < 0.05). To conclude, this study reveals the categories of patients with HHT that are prone to immunosuppression and require careful monitoring, and suggests a potential therapeutic strategy based on the functional activation of neutrophils.

Highlights

  • Hereditary hemorrhagic telangiectasia (HHT), known as Rendu–Osler–Weber disease, is a rare, genetic, systemic disease characterized by mucocutaneous telangiectases and visceral vascular malformations

  • Genetic testing was performed in 22% of the patients (n = 17/79), with seven patients suffering from HHT 1 (n = 7/17, 41%) and five patients from HHT 2 (n = 5/17, 29%)

  • Our data support the hypothesis that the reduced neutrophil functions are caused by impaired cytoskeleton reorganization

Read more

Summary

Introduction

Hereditary hemorrhagic telangiectasia (HHT), known as Rendu–Osler–Weber disease, is a rare, genetic, systemic disease characterized by mucocutaneous telangiectases and visceral vascular malformations. An association between HHT and infectious diseases has been reported. Numerous cases indicated that patients with HHT and pulmonary vascular malformations (PAVMs) or prolonged nasal packings for epistaxis are more susceptible to infections, cerebral abscesses, or septic thrombi [7,8,9,10,11]. A few studies reported life-threatening extracerebral severe infections, including osteoarthritis, septicemia, and spondylodiscitis, typically due to Staphylococcus aureus infection [12,13]. As PAVMs could cause paradoxical embolism of septic material or thrombi [14] preventing bacteremia, an antibiotic prophylaxis according to endocarditis guidelines is recommended for interventions with bacteremia [15]

Objectives
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.